Market Alert : Crude Oil Prices Decline on Easing Geopolitical Risk and Emerging Supply Expectations

Why are Core Lithium, Ampol and Santos shares in focus this Thursday?

Source: Kapitales Research

Highlights:

  • Core Lithium shares fell as investors weighed pre-production risks, negative cash flows, and pending funding approvals despite its Finniss project restart plans.
  • Ampol gained on progress in its EG Australia acquisition, with an updated remedy proposal boosting confidence ahead of the ACCC decision.
  • Santos advanced on strong operational performance, supported by production growth, rising revenues, and key project momentum from Barossa and Pikka.

Stock Moves Today: CXO Declines, ALD and STO Gain

Core Lithium (ASX: CXO) declined 8.80% to AU$0.337, while Ampol Limited (ASX: ALD) rose 1.40% to AU$33.260 and Santos Limited (ASX: STO) gained 3.50% to AU$7.695, reflecting mixed investor sentiment across the energy and resources space.

CXO: Pre-Production Risks Weigh

Core Lithium announced a Final Investment Decision to restart the Finniss Lithium Project and secured a funding package of around AU$290 million, with cash reserves of AU$91.6 million at the end of the March quarter.

However, the stock declined as the company remains in a pre-production phase, meaning there are no immediate operating cash flows. This is reflected in negative operating cash flow of AU$6.3 million for the quarter.

Additionally, investors are factoring in execution risks, including project ramp-up timelines, and approval risks, as parts of the funding package remain subject to shareholder and regulatory approvals. These uncertainties, combined with lithium price volatility, pressured the share price.

ALD: Deal Progress Lifts Sentiment

Ampol shares moved higher after the company submitted a final remedy offer to the ACCC for its proposed EG Australia acquisition. The offer includes four additional sites for divestment, increasing the total from 37 to 41 sites, reflecting continued regulatory engagement.

The Phase 2 ACCC determination is expected by 5 June 2026, with a possible extension of up to 15 business days. The transaction is targeted for completion in mid-2026, subject to regulatory approval and other conditions, supporting investor confidence.

STO: Production Growth and Strong Execution

Santos delivered solid first-quarter performance with production of 22.5 million barrels of oil equivalent, up 3% year-on-year, supported by initial cargoes from the Barossa project. Sales revenue rose to approximately US$1.27 billion, while free cash flow from operations stood around US$383 million.

Operationally, Barossa is ramping up production, while the Pikka Phase 1 project is nearing first oil, expected in 2026. These projects are expected to drive a significant uplift in output, with total production guidance of 101–111 million barrels of oil equivalent for 2026.

Additionally, third-party sales volumes doubled to 4.2 million barrels of oil equivalent, reflecting strategic contract optimisation. Overall, the update highlights strong execution and improving production visibility.

Outlook Ahead

Core Lithium’s near-term outlook remains highly execution-driven, with progress on the Finniss restart, funding approvals, and lithium price trends acting as key catalysts. Ampol’s trajectory will largely depend on ACCC clearance and successful completion of the EG Australia acquisition, which could strengthen its retail fuel network and earnings profile. Santos, on the other hand, appears better positioned with steady production growth, strong free cash flow generation, and upcoming project milestones like Barossa and Pikka supporting long-term operational and financial stability.

Note- All data presented is based on information available at the time of writing.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au